TARA Protara Therapeutics, Inc.

6d ago, source: Seeking Alpha

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead program is ...

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

13d ago, source:

Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026NEW YORK, ...

Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

13d ago, source:

These promising three-month results support the continued development of TARA-002 for patients with NMIBC for whom there are ...

Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity

on MSN ago, source:

Protara Therapeutics Inc (NASDAQ:TARA) shared data from three-month evaluable carcinoma in situ (CIS) patients treated across ...

Protara Therapeutics Inc Ordinary Shares

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Protara Announces Positive Data From TARA-002 Trial In Bladder Cancer; Stock Up

13d ago, source:

Protara Therapeutics, Inc. (TARA) announced positive results on Friday from a three-month evaluation of carcinoma in situ patients ...

Protara Reaches Alignment With FDA On A Registrational Path Forward For IV Choline Chloride

13d ago, source:

Protara Therapeutics, Inc. (TARA) announced Friday that it has reached alignment with the U.S. Food and Drug Administration (FDA) on ...

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition

13d ago, source:

New development pathway significantly expands addressable patient population for IV Choline ChlorideIV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline for ...